Thalidomide and Sacroiliitis - a phase IV clinical study of FDA data

Summary:

Sacroiliitis is reported as a side effect among people who take Thalidomide (thalidomide), especially for people who are female, 60+ old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Sacroiliitis when taking Thalidomide. It is created by eHealthMe based on reports of 16,470 people who have side effects when taking Thalidomide from the FDA, and is updated regularly.

What is Thalidomide?

Thalidomide has active ingredients of thalidomide. eHealthMe is studying from 16,473 Thalidomide users. Check the latest studies of Thalidomide.

What is Sacroiliitis?

Sacroiliitis (an inflammation of the sacroiliac joint) is found to be associated with 326 drugs and 529 conditions by eHealthMe. Check the latest studies of Sacroiliitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

16,470 people reported to have side effects when taking Thalidomide.
Among them, 20 people (0.12%) have Sacroiliitis.

Among these 20 people:

What is the gender of people who have Sacroiliitis when taking Thalidomide? *

female: 55 %
male: 45 %

What is the age of people who have Sacroiliitis when taking Thalidomide? *

What are other drugs people take besides Thalidomide? *

What are other side effects people have besides Sacroiliitis? *

High Blood Pressure: 20 people, 100.00%
Joint Pain: 20 people, 100.00%
Osteonecrosis Of Jaw (death of bone of jaw): 20 people, 100.00%
Osteomyelitis (infection of bone): 19 people, 95.00%
Hypoaesthesia (reduced sense of touch or sensation): 17 people, 85.00%
Aortic Arteriosclerosis (hardening of the aortic arteries): 17 people, 85.00%
Hyperlipidaemia (presence of excess lipids in the blood): 17 people, 85.00%
Neuropathy Peripheral (surface nerve damage): 17 people, 85.00%
Aortic Stenosis (obstruction to the outflow of blood from the left ventricle into the aorta): 17 people, 85.00%
Muscle Aches (muscle pain): 17 people, 85.00%

What are the existing conditions these people have? *

Seasonal Allergy (allergic condition due to certain season): 9 people, 45.00%
Multiple Myeloma (cancer of the plasma cells): 9 people, 45.00%
Pain: 3 people, 15.00%
Metastases To Bone (cancer spreads to bone): 3 people, 15.00%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 1 person, 5.00%
General Anaesthesia: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Thalidomide and have Sacroiliitis?

- Check whether Sacroiliitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Thalidomide:

Thalidomide (16,473 reports)

Sacroiliitis treatments and more:

Sacroiliitis (3,290 reports)

Browse all side effects of Thalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sacroiliitis:

Sacroiliitis (326 drugs)

Browse all the conditions that are associated with Sacroiliitis:

Sacroiliitis (529 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on thalidomide (the active ingredients of Thalidomide) and Thalidomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.